Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas https://www.biorxiv.org/content/10.1101/2022.12.07.519545v1?med=mas
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas https://www.biorxiv.org/content/10.1101/2022.12.07.519545v1?med=mas